• Home
  • Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.

Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.

Author List
Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY
Publication
Hepatology (Baltimore, Md.)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/33795536
Publication Year
2019
PubMed ID
30548884
Publication Title
Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes. Hepatology. 2019 03; 69(3):1193-1205.